Candriam SCA’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $159M | Buy |
1,322,654
+46,967
| +4% | +$5.42M | 0.83% | 22 |
|
|
2025
Q4 | $134M | Sell |
1,275,687
-143,474
| -10% | -$13.5M | 0.67% | 25 |
|
|
2025
Q3 | $119M | Sell |
1,419,161
-234,938
| -14% | -$19.4M | 0.62% | 30 |
|
|
2025
Q2 | $131M | Sell |
1,654,099
-494,389
| -23% | -$39.3M | 0.76% | 23 |
|
|
2025
Q1 | $193M | Sell |
2,148,488
-68,935
| -3% | -$6.44M | 1.21% | 13 |
|
|
2024
Q4 | $221M | Sell |
2,217,423
-248,291
| -10% | -$25.6M | 1.27% | 10 |
|
|
2024
Q3 | $280M | Buy |
2,465,714
+85,249
| +4% | +$10.1M | 1.61% | 8 |
|
|
2024
Q2 | $295M | Sell |
2,380,465
-92,865
| -4% | -$12M | 1.79% | 6 |
|
|
2024
Q1 | $326M | Sell |
2,473,330
-556,959
| -18% | -$68.6M | 2.09% | 5 |
|
|
2023
Q4 | $330M | Sell |
3,030,289
-305,310
| -9% | -$31.7M | 2.28% | 4 |
|
|
2023
Q3 | $343M | Buy |
3,335,599
+209,628
| +7% | +$22.6M | 2.43% | 7 |
|
|
2023
Q2 | $361M | Sell |
3,125,971
-344,091
| -10% | -$39.1M | 2.61% | 3 |
|
|
2023
Q1 | $340M | Buy |
3,470,062
+264,370
| +8% | +$28.5M | 2.36% | 4 |
|
|
2022
Q4 | $356M | Sell |
3,205,692
-272,866
| -8% | -$27.9M | 2.4% | 4 |
|
|
2022
Q3 | $300M | Sell |
3,478,558
-3,480
| -0.1% | -$311K | 2.11% | 4 |
|
|
2022
Q2 | $317M | Sell |
3,482,038
-58,091
| -2% | -$5.15M | 2.61% | 4 |
|
|
2022
Q1 | $290M | Buy |
3,540,129
+887,274
| +33% | +$70M | 1.98% | 4 |
|
|
2021
Q4 | $203M | Sell |
2,652,855
-1,010,324
| -28% | -$80.5M | 1.3% | 8 |
|
|
2021
Q3 | $275M | Sell |
3,663,179
-655,128
| -15% | -$49.8M | 1.87% | 4 |
|
|
2021
Q2 | $336M | Buy |
4,318,307
+486,168
| +13% | +$36.2M | 2.3% | 4 |
|
|
2021
Q1 | $287M | Buy |
3,832,139
+4
| +0% | +$295 | 2.39% | 5 |
|
|
2020
Q4 | $299M | Buy |
3,832,135
+757,091
| +25% | +$57.9M | 2.37% | 5 |
|
|
2020
Q3 | $243M | Buy |
3,075,044
+938,625
| +44% | +$73.5M | 2.29% | 5 |
|
|
2020
Q2 | $158M | Buy |
2,136,419
+675,881
| +46% | +$50.9M | 1.66% | 7 |
|
|
2020
Q1 | $124M | Buy |
1,460,538
+135
| +0% | +$10.6K | 1.37% | 11 |
|
|
2019
Q4 | $127M | Sell |
1,460,403
-186,921
| -11% | -$15.4M | 1.36% | 11 |
|
|
2019
Q3 | $132M | Sell |
1,647,324
-110,106
| -6% | -$8.82M | 1.75% | 9 |
|
|
2019
Q2 | $141M | Buy |
1,757,430
+124,976
| +8% | +$9.57M | 1.76% | 7 |
|
|
2019
Q1 | $130M | Buy |
1,632,454
+584,394
| +56% | +$43.7M | 1.67% | 9 |
|
|
2018
Q4 | $76.4M | Sell |
1,048,060
-253,420
| -19% | -$17.9M | 1.17% | 12 |
|
|
2018
Q3 | $88.1M | Buy |
1,301,480
+856,912
| +193% | +$54.6M | 1.17% | 12 |
|
|
2018
Q2 | $25.8M | Sell |
444,568
-171,066
| -28% | -$9.65M | 0.41% | 50 |
|
|
2018
Q1 | $32M | Buy |
615,634
+60,226
| +11% | +$3.25M | 0.55% | 31 |
|
|
2017
Q4 | $29.8M | Sell |
555,408
-65,736
| -11% | -$3.64M | 0.52% | 41 |
|
|
2017
Q3 | $38M | Sell |
621,144
-14,898
| -2% | -$903K | 0.66% | 24 |
|
|
2017
Q2 | $38.9M | Buy |
636,042
+309,467
| +95% | +$18.8M | 0.73% | 21 |
|
|
2017
Q1 | $19.8M | Sell |
326,575
-14,664
| -4% | -$890K | 0.38% | 55 |
|
|
2016
Q4 | $19.2M | Sell |
341,239
-170,602
| -33% | -$9.98M | 0.44% | 52 |
|
|
2016
Q3 | $30.5M | Buy |
511,841
+96,037
| +23% | +$5.62M | 0.73% | 25 |
|
|
2016
Q2 | $22.9M | Sell |
415,804
-202,480
| -33% | -$10.8M | 0.59% | 41 |
|
|
2016
Q1 | $31M | Buy |
618,284
+36,731
| +6% | +$1.8M | 0.78% | 23 |
|
|
2015
Q4 | $29.3M | Sell |
581,553
-169,750
| -23% | -$8.56M | 0.78% | 26 |
|
|
2015
Q3 | $35.4M | Sell |
751,303
-83,321
| -10% | -$4.43M | 0.87% | 16 |
|
|
2015
Q2 | $45.3M | Sell |
834,624
-68,050
| -8% | -$3.82M | 0.94% | 14 |
|
|
2015
Q1 | $49.5M | Buy |
902,674
+34,215
| +4% | +$1.94M | 1% | 13 |
|
|
2014
Q4 | $47.1M | Buy |
+868,459
| New | +$48.4M | 0.98% | 13 |
|
Other funds holding MRK
VCM
VPM
Candriam SCA's MRK Position: Q1 2026 in Review
Candriam SCA increased its Merck (MRK) stake by 3.7% in Q1 2026, buying an estimated $5.42M and bringing the position to 1,322,654 shares worth $159M. The position accounts for 0.83% of the portfolio, ranked #22.
Candriam SCA first reported a position in MRK in Q4 2014 and has held it in 46 quarters since. The position peaked at $361M in Q2 2023. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Candriam SCA held 1,322,654 shares of Merck worth $159M as of Q1 2026.
- Candriam SCA bought 46,967 Merck shares in Q1 2026, an estimated $5.42M.
- Merck made up 0.83% of Candriam SCA's portfolio in Q1 2026, its #22 holding.
- Candriam SCA first reported a position in Merck in Q4 2014 and has held it in 46 quarters since.
- Candriam SCA's Merck position peaked at $361M in Q2 2023.
- 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Candriam SCA's 13F filing for Q1 2026, filed 30 Apr 2026.